C Thieblemont
Overview
Explore the profile of C Thieblemont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moatti H, Brice P, Laroque M, Di Blasi R, Wencel J, Delory T, et al.
Hematol Oncol
. 2024 Dec;
43(1):e70031.
PMID: 39731781
Brentuximab vedotin (BV)-bendamustine (90 or 120 mg/m2 day 1 and 2) every 28 days is an effective treatment for relapsed/refractory Hodgkin lymphoma (R/R HL) but associated to high toxicity especially...
2.
Bommier C, Donzel M, Rossi C, Fornecker L, Bijou F, Chauchet A, et al.
Hematol Oncol
. 2024 Oct;
42(6):e3314.
PMID: 39351974
Marginal Zone Lymphoma (MZL) comprises three subtypes: extranodal MZL (EMZL), splenic MZL (SMZL) and nodal MZL (NMZL). Since clinical trials have limited representativeness, there is a need for real-world data...
3.
Zucca E, Arcaini L, Buske C, Johnson P, Ponzoni M, Raderer M, et al.
Ann Oncol
. 2022 Dec;
34(3):325.
PMID: 36529567
No abstract available.
4.
Hayden P, Roddie C, Bader P, Basak G, Bonig H, Bonini C, et al.
Ann Oncol
. 2021 Dec;
33(3):259-275.
PMID: 34923107
Background: Several commercial and academic autologous chimeric antigen receptor T-cell (CAR-T) products targeting CD19 have been approved in Europe for relapsed/refractory B-cell acute lymphoblastic leukemia, high-grade B-cell lymphoma and mantle...
5.
Vernier V, Ursu R, Belin C, Maillet D, Thieblemont C, Carpentier A
Rev Neurol (Paris)
. 2021 Jun;
178(3):282-284.
PMID: 34176661
No abstract available.
6.
Cottereau A, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L, et al.
Ann Oncol
. 2020 Dec;
32(3):404-411.
PMID: 33278600
Background: We analyzed the prognostic value of a new baseline positron emission tomography (PET) parameter reflecting the spread of the disease, the largest distance between two lesions (Dmax). We tested...
7.
Severyns T, Kirchgesner J, Lambert J, Thieblemont C, Amiot A, Abitbol V, et al.
J Crohns Colitis
. 2020 Mar;
14(9):1222-1230.
PMID: 32161943
Background And Aims: The prognosis of lymphoma that occurs in patients with inflammatory bowel disease [IBD] is poorly known. Methods: A multicentre retrospective cohort analysis was done in seven French...
8.
Zucca E, Arcaini L, Buske C, Johnson P, Ponzoni M, Raderer M, et al.
Ann Oncol
. 2020 Jan;
31(1):17-29.
PMID: 31912792
No abstract available.
9.
Milcent B, Josseaume N, Petitprez F, Riller Q, Amorim S, Loiseau P, et al.
Sci Rep
. 2019 Sep;
9(1):13471.
PMID: 31530876
Preclinical models and clinical studies have shown that anti-CD20-based treatment has multifaceted consequences on T-cell immunity. We have performed a prospective study of peripheral T-cell compartment in FL patients, all...
10.
Rule S, Jurczak W, Jerkeman M, Rusconi C, Trneny M, Offner F, et al.
Leukemia
. 2018 Mar;
32(8):1799-1803.
PMID: 29572505
No abstract available.